Swiss National Bank’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89M | Buy |
172,200
+10,300
| +6% | +$293K | ﹤0.01% | 1314 |
|
|
2025
Q1 | $4.78M | Sell |
161,900
-12,500
| -7% | -$369K | ﹤0.01% | 1287 |
|
|
2024
Q4 | $5.07M | Buy |
174,400
+18,800
| +12% | +$547K | ﹤0.01% | 1324 |
|
|
2024
Q3 | $7.15M | Sell |
155,600
-800
| -0.5% | -$36.7K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $6.39M | Buy |
156,400
+15,600
| +11% | +$637K | ﹤0.01% | 1126 |
|
|
2024
Q1 | $3.59M | Buy |
140,800
+24,000
| +21% | +$612K | ﹤0.01% | 1506 |
|
|
2023
Q4 | $1.06M | Sell |
116,800
-7,700
| -6% | -$69.7K | ﹤0.01% | 2215 |
|
|
2023
Q3 | $794K | Sell |
124,500
-6,500
| -5% | -$41.5K | ﹤0.01% | 2369 |
|
|
2023
Q2 | $1.45M | Buy |
131,000
+16,200
| +14% | +$180K | ﹤0.01% | 2096 |
|
|
2023
Q1 | $1.76M | Sell |
114,800
-19,600
| -15% | -$301K | ﹤0.01% | 1909 |
|
|
2022
Q4 | $2.98M | Buy |
134,400
+45,900
| +52% | +$1.02M | ﹤0.01% | 1642 |
|
|
2022
Q3 | $1.45M | Buy |
88,500
+5,300
| +6% | +$86.5K | ﹤0.01% | 2097 |
|
|
2022
Q2 | $1.21M | Hold |
83,200
| – | – | ﹤0.01% | 2259 |
|
|
2022
Q1 | $1.54M | Buy |
83,200
+8,000
| +11% | +$148K | ﹤0.01% | 2184 |
|
|
2021
Q4 | $1.79M | Hold |
75,200
| – | – | ﹤0.01% | 2139 |
|
|
2021
Q3 | $1.85M | Buy |
75,200
+38,000
| +102% | +$936K | ﹤0.01% | 2106 |
|
|
2021
Q2 | $919K | Buy |
37,200
+7,500
| +25% | +$185K | ﹤0.01% | 2512 |
|
|
2021
Q1 | $648K | Hold |
29,700
| – | – | ﹤0.01% | 2431 |
|
|
2020
Q4 | $758K | Buy |
+29,700
| New | +$758K | ﹤0.01% | 2394 |
|